We already reported elevated plasma levels of IL-6 in patients with MPN and that IL-6 stimulated JAK2/STAT3 and AKT signaling in polycythemia vera (PV) and primary myelofibrosis (PMF) [6]. Here, JAK2 is linked to myeloproliferative disorder.